Sharescart Research Club logo

Key Financials Snapshot

TTM · Standalone · ₹ in Cr
Market Cap
₹530 Cr.
Stock P/E
14.6
P/B
1
Current Price
₹40
Book Value
₹ 41.4
Face Value
1
52W High
₹47.8
52W Low
₹ 35.3
Dividend Yield
6.25%

PTL Enterprises Overview

Business

PTL Enterprises Ltd. is primarily engaged in a unique business model revolving around asset leasing and diversified investments. Its core business involves leasing out its tyre manufacturing plant located in Kochi, Kerala, to Apollo Tyres Ltd. This long-standing lease agreement provides a significant portion of its stable, recurring revenue. Beyond this, PTL has diversified its operations to include healthcare services (through its investment in KIMSHEALTH Hospital, Kochi), modest wind power generation, and a portfolio of strategic investments in various listed and unlisted entities. Essentially, PTL generates income from lease rentals, healthcare operations, power sales, and returns from its investment portfolio.

Revenue Mix

While specific percentage breakdowns can fluctuate, PTL's revenue streams primarily originate from:

Lease Rentals: The most significant and stable component, derived from the long-term lease of its tyre manufacturing plant to Apollo Tyres Ltd.

Healthcare Services: Revenue from the operation of hospitals, primarily KIMSHEALTH Hospital in Kochi, through an associate company. This segment has been growing and represents a substantial portion outside of lease rentals.

Power Generation: Minor revenue from the generation and sale of wind power.

Investment Income: Returns, dividends, and capital gains from its diverse investment portfolio.

The lease rentals from Apollo Tyres typically form the largest and most predictable part of its income.

Industry

PTL operates in a multi-faceted manner rather than a single industry.

Asset Leasing (Tyre Plant): In this unique niche, PTL acts as a landlord for a major industrial asset. It doesn't directly compete in tyre manufacturing but benefits from the stability of its tenant, Apollo Tyres.

Healthcare: Through its associate, PTL is positioned within the competitive Indian healthcare sector, specifically in the tertiary care segment in Kerala. It competes with other regional and national hospital chains.

Investments: It operates as an investment holding company to some extent, competing with other institutional or individual investors.

Its positioning is somewhat unique due to the stable base provided by the Apollo Tyres lease, allowing it to explore and diversify into other capital-intensive sectors like healthcare.

MOAT

PTL's primary competitive advantage or "moat" stems from:

Long-Term Lease Agreement: The established and long-standing lease agreement with Apollo Tyres Ltd. for its manufacturing plant provides a highly stable and predictable stream of recurring revenue. This contractual arrangement reduces operational risk associated with manufacturing and market fluctuations.

Diversified Asset Base: The diversification into healthcare and a strategic investment portfolio provides multiple streams of income, mitigating over-reliance on a single asset or industry, though the lease income remains dominant.

Brand and Management (Healthcare): In the healthcare segment, KIMSHEALTH has established a regional brand presence and reputation in Kerala, which can create patient loyalty and trust.

Growth Drivers

Growth in Healthcare Services: Expansion of KIMSHEALTH Hospital's operations, increase in patient footfall, and potential addition of new facilities or specialized services. The growing demand for quality healthcare in India supports this segment.

Performance of Investment Portfolio: Strategic investments in other businesses, if successful, can lead to capital appreciation and higher dividend income.

Lease Renewal Terms: While a stable income, future renegotiations or renewals of the Apollo Tyres lease agreement could potentially lead to revised (upward) rental terms, providing a boost to income.

Operational Efficiency: Improving efficiency in its diversified segments, particularly healthcare, can drive profitability.

Risks

Dependence on Apollo Tyres Lease: A significant portion of PTL's revenue is derived from the lease agreement with Apollo Tyres. Any adverse changes to this agreement, the financial health of Apollo Tyres, or the eventual terms of its renewal could significantly impact PTL's financials.

Healthcare Sector Risks: The healthcare industry is highly competitive, capital-intensive, and subject to regulatory changes, pricing pressures, and the need for continuous technological upgrades. Operational challenges or economic downturns affecting healthcare spending could impact profitability.

Investment Volatility: The performance of PTL's investment portfolio is subject to market risks, economic cycles, and the specific performance of the underlying companies, leading to potential fluctuations in asset values and returns.

Regulatory Risks: Changes in government policies, healthcare regulations, environmental norms, or corporate governance standards in India could affect its operations across segments.

Management & Ownership

PTL Enterprises Ltd. has a history intertwined with the larger Indian tyre industry, with past associations involving key figures in this sector. The company's promoters, as reported in public filings, typically hold a significant stake, demonstrating alignment with shareholder interests. Management quality is generally seen as stable, focusing on maintaining the core lease income and strategically diversifying into growing sectors like healthcare. The ownership structure includes promoter holding, institutional investors, and public shareholders, typical for a listed Indian company.

Outlook

PTL Enterprises presents a unique investment profile characterized by a stable base and diversification efforts. The primary bull case rests on the consistent, predictable cash flow from its long-term lease agreement with Apollo Tyres, which provides a strong foundation. This stability allows the company to strategically invest and grow its healthcare segment, which benefits from robust demand in India. Successful expansion and operational efficiency in KIMSHEALTH, coupled with prudent management of its investment portfolio, could unlock further value and drive earnings growth.

Conversely, the bear case highlights the significant dependence on the Apollo Tyres lease – any disruption or unfavorable renegotiation of this agreement could severely impact the company. The healthcare sector, while promising, is highly competitive and capital-intensive, requiring sustained investment and skilled management to navigate. Economic downturns, increased competition in healthcare, and volatility in its investment portfolio also pose risks. Overall, PTL offers a blend of stability from its legacy asset and potential upside from its diversified ventures, but with inherent risks tied to sector-specific challenges and its core contractual arrangement.

PTL Enterprises Share Price

Live · BSE / NSE · Inception: 1959
| |
Volume
Price

Key Financials — Profit & Loss

₹ in Cr · Standalone · annual

PTL Enterprises Quarterly Results

#(Fig in Cr.) Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Net Sales 16 16 16 16 16 16 16 16 16 16
Other Income 0 0 0 7 0 0 0 6 0 4
Total Income 16 16 16 23 16 16 16 22 16 20
Total Expenditure 1 1 2 1 1 2 1 1 2 1
Operating Profit 15 15 15 21 15 15 15 20 15 19
Interest 1 1 1 1 1 1 1 1 1 1
Depreciation 1 1 1 1 1 1 1 1 1 1
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 13 13 13 19 13 13 13 19 13 17
Provision for Tax 7 8 8 5 4 4 4 4 4 4
Profit After Tax 5 6 5 14 8 9 9 15 9 13
Adjustments 0 0 0 0 -0 0 0 0 0 0
Profit After Adjustments 5 6 5 14 8 9 9 15 9 13
Adjusted Earnings Per Share 0.4 0.4 0.4 1.1 0.6 0.7 0.7 1.1 0.7 1

PTL Enterprises Profit & Loss

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
Net Sales 40 46 53 60 63 63 63 63 64 64 64 64
Other Income 2 1 2 11 3 4 7 4 4 6 7 10
Total Income 42 47 56 71 66 67 71 67 69 70 71 74
Total Expenditure 9 4 5 4 5 5 6 6 6 8 6 5
Operating Profit 32 43 51 68 61 61 65 61 62 61 65 69
Interest 8 5 3 6 2 2 7 7 7 6 5 4
Depreciation 1 1 1 1 1 1 2 2 2 2 2 4
Exceptional Income / Expenses 0 0 0 0 0 0 29 0 0 0 0 0
Profit Before Tax 23 38 47 61 58 58 86 52 53 54 58 62
Provision for Tax 8 13 16 15 18 14 15 19 30 30 22 16
Profit After Tax 15 24 30 46 40 44 70 33 23 24 36 46
Adjustments 0 0 0 0 0 0 0 0 0 0 0 0
Profit After Adjustments 15 24 30 46 40 44 70 33 23 24 36 46
Adjusted Earnings Per Share 1.1 1.8 2.3 3.5 3 3.3 5.3 2.5 1.8 1.8 2.7 3.5

PTL Enterprises Balance Sheet

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Shareholder's Funds 88 681 436 472 488 447 595 583 700 843 851
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 30 0 0 0 0 0 45 43 21 13 5
Other Non-Current Liabilities 53 63 176 185 325 336 364 361 210 226 190
Total Current Liabilities 117 118 125 14 17 19 23 23 243 274 291
Total Liabilities 288 861 737 670 830 802 1027 1011 1173 1357 1336
Fixed Assets 16 593 599 595 594 600 610 612 612 610 608
Other Non-Current Assets 180 164 1 57 234 197 366 377 345 503 459
Total Current Assets 92 104 137 19 2 5 52 21 216 244 269
Total Assets 288 861 737 670 830 802 1027 1011 1173 1357 1336

PTL Enterprises Cash Flow

#(Fig in Cr.) Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 2 3 1 15 17 1 0 0 6 1 1
Cash Flow from Operating Activities 26 65 25 48 42 46 40 41 43 21 26
Cash Flow from Investing Activities 0 -5 -6 -35 -43 -7 -68 -14 4 11 7
Cash Flow from Financing Activities -26 -62 -5 -10 -16 -40 28 -20 -52 -33 -33
Net Cash Inflow / Outflow 0 -2 14 2 -17 -0 -0 6 -5 -0 0
Closing Cash & Cash Equivalent 3 1 15 17 1 0 0 6 1 1 1

PTL Enterprises Ratios

# Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Earnings Per Share (Rs) 1.14 1.83 2.29 3.46 3.01 3.32 5.29 2.49 1.76 1.78 2.74
CEPS(Rs) 1.21 1.88 2.36 3.55 3.1 3.41 5.41 2.63 1.91 1.94 2.9
DPS(Rs) 0.5 0.5 0.63 1 1.25 1.25 2.5 2 1.75 1.75 1.75
Book NAV/Share(Rs) 6.67 7.9 10.58 13.4 14.6 11.51 22.7 21.72 30.55 41.37 41.96
Core EBITDA Margin(%) 76.64 91.33 90.61 94.08 92.51 91.43 90.86 90.11 90.03 86.87 90.63
EBIT Margin(%) 78.17 92.98 92.84 110.7 95.19 95.09 146.42 93.89 93.35 92.26 97.9
Pre Tax Margin(%) 58.09 82.06 87.27 100.51 92.16 91.74 135.28 82.33 82.9 83.4 89.89
PAT Margin (%) 37.62 52.88 56.65 76.05 63.04 69.49 110.79 52.18 36.18 36.61 56.41
Cash Profit Margin (%) 39.92 54.29 58.41 78.02 64.96 71.46 113.33 55.04 39.37 39.87 59.65
ROA(%) 5.31 4.22 3.79 6.51 5.31 5.38 7.66 3.24 2.13 1.86 2.7
ROE(%) 17.75 25.13 24.77 28.88 21.51 25.42 30.93 11.22 6.73 4.95 6.58
ROCE(%) 22.53 35.27 40.59 42.04 32.48 34.79 36.95 17.32 15.61 11.86 11.07
Receivable days 1.38 0.66 0 0 0 0 0 0 0 0 0
Inventory Days 0.5 0.44 0.38 0 0 0 0 0 0 0 0
Payable days 0 0 0 0 0 0 0 0 0 0 0
PER(x) 14.91 37.17 10.67 6.72 6.92 4.2 3.67 13.32 17.3 21.94 13.68
Price/Book(x) 2.54 8.61 2.31 1.74 1.43 1.21 0.85 1.53 1 0.94 0.89
Dividend Yield(%) 2.95 0.73 2.56 4.3 6 8.98 12.89 6.02 5.75 4.48 4.67
EV/Net Sales(x) 6.72 19.6 5.74 4.81 4.34 2.85 4.11 7.41 6.57 8.33 7.89
EV/Core EBITDA(x) 8.35 20.77 6.07 4.27 4.46 2.93 4.01 7.66 6.8 8.72 7.8
Net Sales Growth(%) 0 14.58 16.65 12.72 4.91 0.01 -0.01 0 1.77 0.01 -0.01
EBIT Growth(%) -12.94 36.29 16.48 34.39 -9.79 -0.1 53.96 -35.87 1.19 -1.16 6.1
PAT Growth(%) -14.58 61.08 24.97 51.32 -13.05 10.24 59.43 -52.9 -29.44 1.22 54.05
EPS Growth(%) -14.58 61.08 24.97 51.32 -13.05 10.24 59.43 -52.9 -29.44 1.22 54.05
Debt/Equity(x) 0.55 0 0 0 0 0 0.16 0.17 0.07 0.04 0.02
Current Ratio(x) 0.79 0.88 1.09 1.35 0.12 0.26 2.28 0.9 0.89 0.89 0.92
Quick Ratio(x) 0.79 0.88 1.09 1.35 0.12 0.26 2.28 0.9 0.89 0.89 0.92
Interest Cover(x) 3.89 8.52 16.66 10.87 31.37 28.36 13.15 8.12 8.93 10.41 12.23
Total Debt/Mcap(x) 0.22 0 0 0 0 0 0.19 0.11 0.07 0.04 0.03

Growth Rates

Compounded annual
# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 0% +1% 0% +5%
Operating Profit CAGR +7% +2% +1% +7%
PAT CAGR +50% +3% -4% +9%
Share Price CAGR -6% +7% +11% -4%
ROE Average +7% +6% +12% +19%
ROCE Average +11% +13% +19% +27%

PTL Enterprises Shareholding Pattern

Latest · Mar 2026
100% held
Promoters 69.82 %
FII 0 %
DII (MF + Insurance) 8.27 %
Public (retail) 30.18 %
# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 69.8269.8269.8269.8269.8269.8269.8269.8269.8269.82
FII 0.0800.030.1000.07000
DII 8.278.278.278.278.278.278.278.278.278.27
Public 30.1830.1830.1830.1830.1830.1830.1830.1830.1830.18
Others 0000000000
Total 100100100100100100100100100100

PTL Enterprises Peer Comparison

Business Support Edit Columns

PTL Enterprises Quarterly Price

10-year quarterly close · BSE
Show Value Show %

News & Updates

See more…

PTL Enterprises Pros & Cons

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of 6% over the last 3 years.
  • The company has delivered a poor profit growth of -3% over past five years.
Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

whatsapp